IBIO, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IBIO, INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $4.00K.
- IBIO, INC. stock issued during period, value, other for the quarter ending 2017-06-30 was $0.00.
- IBIO, INC. stock issued during period, value, other for the quarter ending 2014-03-31 was $12.60M.
- IBIO, INC. stock issued during period, value, other for fiscal 2025 was $5.88M.
- IBIO, INC. stock issued during period, value, other for fiscal 2017 was $0.00.
- IBIO, INC. stock issued during period, value, other for fiscal 2014 was $480.00K, a 87.48% decline from fiscal 2013.
- IBIO, INC. stock issued during period, value, other for fiscal 2013 was $3.83M, a 57.57% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-06-30 | $5.88M 10-K · filed 2025-09-05 | |
| 2024-09-30 | $4.00K 10-Q · filed 2024-11-12 | |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | $0.00 10-K · filed 2018-09-18 |
| 2014-06-30 | $480.00K 10-K · filed 2015-10-13 | |
| 2014-03-31 | $12.60M 10-K · filed 2014-09-29 | |
| 2013-06-30 | $3.83M 10-K/A · filed 2013-10-04 | |
| 2012-06-30 | $9.04M 10-K/A · filed 2013-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |